Literature DB >> 14605830

Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study.

M J Sá1, M D Madeira, C Ruela, B Volk, A Mota-Miranda, M M Paula-Barbosa.   

Abstract

We have previously shown that in the hippocampal formation of patients with acquired immunodeficiency syndrome (AIDS) there is neuronal atrophy, without cell loss. Because reductions in neuronal size are suggestive of associated neuritic alterations, we decided to study the dendritic trees of the main neuronal populations in the hippocampal formation. Material was obtained in five male AIDS patients and five male controls. After Golgi impregnation, the dendritic arborizations of dentate granule and hilar basket cells, and of CA3 and CA1 pyramidal cells, were hand traced, and their segments classified, counted and measured. We found an impoverishment of the dendritic trees in all neuronal populations in the AIDS group, which was more striking in the hilus and CA3 field. Specifically, hilar neurons had fewer dendritic segments, and reduced branching density and dendritic extent; in CA3 pyramids there was a decrease in the number of terminal segments in the basal trees, and a reduction in the total number of segments, number of medium order terminals, dendritic branching density and dendritic extent in the apical trees. In CA1 pyramids, the terminals were shorter in the apical trees and the dendritic spine density decreased in the basal trees, whereas in granule cells only the dendritic spine density was reduced in AIDS patients. Subtle signs suggestive of dendritic reorganization were observed. These results point to a regional vulnerability of the hippocampal formation to HIV infection, and might contribute to explaining the occurrence of dementia, as a consequence of overall reduction in the hippocampal neuronal receptive surface.

Entities:  

Mesh:

Year:  2003        PMID: 14605830     DOI: 10.1007/s00401-003-0781-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  50 in total

1.  Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.

Authors:  A H Shin; H J Kim; S A Thayer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Effects of HIV and early life stress on amygdala morphometry and neurocognitive function.

Authors:  Uraina S Clark; Ronald A Cohen; Lawrence H Sweet; Assawin Gongvatana; Kathryn N Devlin; George N Hana; Michelle L Westbrook; Richard C Mulligan; Beth A Jerskey; Tara L White; Bradford Navia; Karen T Tashima
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

3.  Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms.

Authors:  Anjuli Mishra; Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-05       Impact factor: 4.147

Review 4.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

Review 5.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

6.  Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.

Authors:  Jonathan Pitcher; Anna Abt; Jaclyn Myers; Rachel Han; Melissa Snyder; Alessandro Graziano; Lindsay Festa; Michele Kutzler; Fernando Garcia; Wen-Jun Gao; Tracy Fischer-Smith; Jay Rappaport; Olimpia Meucci
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

7.  Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.

Authors:  Diana Morales; Summer F Acevedo; Richard L Skolasky; Rosa Hechavarria; Sharon Santiago; Tania De La Torre; Elizabeth Maldonado; Valerie Wojna
Journal:  J Neurovirol       Date:  2012-09-13       Impact factor: 2.643

8.  Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.

Authors:  Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2011-06-13       Impact factor: 4.436

9.  Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology.

Authors:  Saori Shimizu; Muhammad Z Khan; Randi L Hippensteel; Anjum Parkar; Ramesh Raghupathi; Olimpia Meucci
Journal:  Neurobiol Dis       Date:  2006-09-28       Impact factor: 5.996

10.  Roles of glutathione in antioxidant defense, inflammation, and neuron differentiation in the thalamus of HIV-1 transgenic rats.

Authors:  Xiaosha Pang; Jun Panee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.